Dementia set to soar

By staff reporter

- Last updated on GMT

The number of people with dementia around the world will double
every 20 years, predicts a new report.

A new case of dementia is diagnosed every seven seconds, according to the paper published in today's Lancet​, or 4.6 million each year.

By 2040 the numbers with dementia will have risen to 81.1 million, from 24.3 million today.

The authors, commissioned by Alzheimer's Disease International (ADI), warn that the illness is a 'ticking time bomb' for governments around the globe.

The figures will give further impetus to research into dietary approaches that can help prevent or slow the onset of the disease. A study published this month in the Archives of Neurology found that people who ate two or more fish meals a week had a slower rate of cognitive decline than non-fish eaters.

Further work is needed to understand this association and establish the mechanism if fish, or fish oils, do indeed help prevent the disease.

Other work has looked at the role of B vitamins in lower homocysteine levels that are linked to Alzheimer's disease, and herbals such as gingko biloba are also thought to offer some benefit to the ageing brain.

Preventative approaches would be of major advantage in lowering the costs associated with this disease, which occurs much more frequently in resource-poor countries.

There are 5 million people with dementia in China alone. This compares with 4.8 million in Western Europe and 3.4 million in North America.

And the rate of growth of dementia in the developing world is predicted to be three to four times higher than in developed areas. By 2040 there will be as many people with dementia in China alone as in the whole of the developed world put together, predicts the report.

Sucharithra Narayanan, senior research analyst for Frost & Sullivan, recently told NutraIngredients-USA.com that mental health was emerging as a new health platform being targetted by supplement makers.

But while manufacturers are starting to target the 30+ market, there are still very few mental health products on the market.

"More studies will drive the market,"​ said Narayanan

Related topics Research Suppliers Cognitive function

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Research to Reality: Restorative Sleep

Research to Reality: Restorative Sleep

Content provided by Gencor | 02-Sep-2024 | White Paper

Gencor prides itself on its cutting-edge, science-driven solutions. Explore sleep support through gold-standard, clinically-validated dietary supplement...

Go Beyond Ordinary in Cognitive Health - BacoMind™

Go Beyond Ordinary in Cognitive Health - BacoMind™

Content provided by Natural Remedies Pvt. Ltd. | 26-Jun-2024 | White Paper

BacoMind™, this groundbreaking, clinically proven, and pioneering Bacopa monnieri extract unleashes the power of 9 bioactive compounds to organically boost...

Related suppliers

Follow us

Products

View more

Webinars